TOZORAKIMAB

UNII:	OHZ2MEL7FD
Formula:
Preferred Substance Name:	TOZORAKIMAB
GSRS Full Record:	OHZ2MEL7FD i

2376858-66-9
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 33) (HUMAN MONOCLONAL MEDI3506 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI3506 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(HOMO SAPIENS IL33 (INTERLEUKIN 33, DVS27, NF-HEV, IL1F11)), MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-456) (VH (HOMO SAPIENS IGHV3-23*01 (93.9%) -(IGHD) -IGHJ4*01 (85.7%) L123>M (121)) CDR-IMGT (8.8.19) (26-33.51-58.97-115) (1-126) -HOMO SAPIENS IGHG1*03 (100%) G1M3, NG1M1 (CH1 R120 (223) (127-224), HINGE 1-15 (225-239), CH2 (240-349), CH3 E12 (365), M14 (367) (350-454), CHS (455-456)) (127-456)), (229-211')-DISULFIDE WITH LAMBDA2 LIGHT CHAIN (1'-212') (V-LAMBDA (HOMO SAPIENS IGLV3-1*01 (86.2%) -IGLJ2*01 (100%)) CDR-IMGT (6.3.9) (26-31.49-51.88-96) (1'-106') -HOMO SAPIENS IGLC2*01 (100%) (107'-212')); DIMER (235-235'':238-238'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO) CELL LINE DERIVED FROM CHO-K1, GLYCOFORM ALFA
MEDI3506
MEDI-3506
TOZORAKIMAB [INN]
TOZORAKIMAB [USAN]
TOZORAKIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TOZORAKIMAB

Synonyms and Mappings

Resources